Form 4: Edwards Lifesciences CEO Transfers Shares to Family Trust

CEO Bernard J. Zovighian transferred shares of Edwards Lifesciences common stock to a family trust.

Summary

• On May 16, 2025, Bernard J. Zovighian, CEO of Edwards Lifesciences Corp, transferred 5,815.5511 shares of EW common stock directly held to his Family Trust for no consideration.
• Following the transaction, Zovighian directly owns 80,976 shares of common stock.
• He also indirectly owns 25,662.5511 shares through a trust and 3,605.8487 shares through a 401(k).

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing detailing a share transfer. It doesn't inherently convey positive or negative sentiment about the company's performance or future prospects.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This transaction represents a transfer of assets for estate planning purposes and is not necessarily indicative of a change in sentiment regarding the company's prospects.

Related Party Transactions

• The transfer of shares to the CEO's family trust constitutes a related party transaction.

Stakeholder Impact

• The transaction has minimal impact on stakeholders as it is a transfer of shares for estate planning purposes and does not affect the company's operations or financial position.

Key Dates

Keywords

Edwards Lifesciences, Zovighian, Share Transfer, Beneficial Ownership, Form 4, Family Trust, CEO